Medicines Development for Global Health | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Better Options for Lymphatic Filariasis Treatment	Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Nematoda infectious disease, Rhabditida infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, filarial elephantiasis, filariasis, helminthiasis, lymphatic system disorder, lymphedema, mite infestation, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, strongyloidiasis, vector-borne disease	Recruiting	Phase 3	2026-10-07		NCT07159373
Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction	Erythema Nodosum Leprosum	Recruiting	Phase 2	2026-10-06		NCT07172659
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis	Infections, Nematoda infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, filariasis, helminthiasis, onchocerciasis, parasitic infectious disease, parasitic skin disorder, skin disorder, skin disorder caused by infection	Active, not recruiting	Phase 3	2025-12-23		NCT03876262
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases	Adenophorea Infections, Enoplea infectious disease, Hookworm Infections, Infections, Nematoda infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, Strongylida infectious disease, filariasis, helminthiasis, mite infestation, onchocerciasis, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, trichuriasis	Recruiting	Phase 4	2025-11-21		NCT07145736